Advertisement Fidelity
Home > Boards > US Listed > Biotechs > Peregrine Pharmaceuticals (PPHM)

PPHM - O/S Shares History (’06–curr.) – a/o

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
cjgaddy Member Profile
 
Followed By 48
Posts 4,150
Boards Moderated 1
Alias Born 01/24/04
160x600 placeholder
Peregrine Pharmaceuticals Announces Initiation of an Investigator-Sponsored Trial Combining Its Immunotherapy Bavituximab & I... "Marketwired" - 4/23/2014 7:30:00 AM
Healthcare Companies Report Results, Patents, and Stock Movements - Analyst Notes on Puma Biotechnology, Alnylam, INSYS Thera... "PR Newswire (US)" - 4/10/2014 12:28:00 PM
Data Presented at AACR Support Potential of Peregrine's PS-Targeting Immunotherapy Bavituximab to Enhance Anti-Tumor & Immune... "Marketwired" - 4/9/2014 11:00:00 AM
Morning Review on Top Gainers -- Research on Peregrine Pharma, Agios Pharma, Idenix Pharma, and Lexicon Pharma "PR Newswire (US)" - 4/8/2014 1:15:00 PM
Data Presented at AACR Support Potential of Combining Peregrine's PS-Targeting Immunotherapy Agent Bavituximab With Irradiati... "Marketwired" - 4/7/2014 8:00:00 AM
Peregrine Pharmaceuticals Announces Three Abstracts Accepted for Presentation at AACR 2014 Annual Meeting "Marketwired" - 4/1/2014 4:00:00 PM
Presentation at Annual Society of Surgical Oncology Meeting Updates Progress in Investigator-Sponsored Phase i/ii Trial of Pe... "Marketwired" - 3/14/2014 8:00:00 AM
Preclinical Data Presentations at Keystone Symposia Highlight Broad Immunotherapy Potential of Peregrine Pharmaceuticals' PS-... "Marketwired" - 3/13/2014 8:00:00 AM
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock "Marketwired" - 3/11/2014 4:10:00 PM
Data Presentations at Keystone Symposium Support Potential of Peregrine Pharmaceuticals' PS-Targeting Antibodies to Overcome ... "Marketwired" - 3/11/2014 8:00:00 AM
Peregrine Pharmaceuticals Reports Third Quarter Fiscal Year 2014 Financial Results and Recent Developments "Marketwired" - 3/7/2014 8:00:00 AM
Pre-Market Review of Top Gainers: Canadian Solar, Qihoo 360 Technology, Peregrine Pharma, Renren, and UTi Worldwide "PR Newswire (US)" - 3/5/2014 10:40:00 AM
Peregrine Pharmaceuticals PS-Targeting Immunotherapy Platform to Be Highlighted in Three Data Presentations at Keystone Sympo... "Marketwired" - 3/4/2014 4:00:00 PM
Peregrine Pharmaceuticals to Report Third Quarter Fiscal Year 2014 Financial Results Before Market Open on March 7, 2014 "Marketwired" - 2/27/2014 4:00:00 PM
Peregrine Pharmaceuticals Announces Partial Exercise of Overallotment Option in Connection With Preferred Stock Offering "Marketwired" - 2/27/2014 12:18:24 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/19/2014 4:11:21 PM
Peregrine Pharmaceuticals Announces Upcoming Events "Marketwired" - 2/19/2014 4:00:00 PM
Peregrine Pharmaceuticals Announces Closing of Preferred Stock Offering "Marketwired" - 2/19/2014 10:15:17 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/12/2014 5:23:36 PM
Securities Registration (section 12(b)) (8-a12b) "Edgar (US Regulatory)" - 2/12/2014 5:20:59 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 2/12/2014 5:01:05 PM
Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) "Edgar (US Regulatory)" - 2/11/2014 8:10:52 AM
Peregrine Pharmaceuticals Prices Offering of Its Series E Preferred Stock "Marketwired" - 2/11/2014 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/6/2014 5:28:09 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/5/2014 4:20:45 PM
cjgaddy   Sunday, 08/19/12 09:42:23 AM
Re: cjgaddy post# 84300
Post # of 173986 
PPHM - O/S Shares History (’06–curr.) – a/o 8-16-12, shares outstanding = 104,191,176, up 17,120 since 7-13-12.

4-30-06 35,876,438
1-31-07 39,222,440
4-30-07 39,222,440
7-6-07 45,233,123
7-31-07 45,242,123
10-31-07 45,242,123
1-31-08 45,242,123
4-30-08 45,242,123
7-31-08 45,242,123
10-31-08 45,242,123
1-31-09 45,242,123
4-30-09 45,537,711
7-10-09 47,392,883
7-31-09 47,393,783
10-31-09 48,869,563 +1,475,780
1-31-10 50,903,404 +2,033,841
4-30-10 53,094,894 +2,191,490
6-21-10 54,388,917 +1,294,023 (6-22-10 ATM/mlv Form424)
7-9-10 55,069,449 +475,987 (4-30-10 10K iss. 7-14-10)
7-31-10 55,784,955 +715,506
10-31-10 59,220,742 +3,435,787
11-30-10 63,932,353 +4,711,611 (10-31-10 10Q iss. 12-9-10)
12-15-10 64,404,097 +471,744 (12-17-10 S-3: $75M Shelf Reg.)
1-31-11 66,813,419 +2,409,322
2-28-11 67,885,811 +1,072,392 (1-31-11 10Q iss. 3-11-11)
4-30-11 69,837,142 +1,951,331
7-8-11 71,069,858 +1,232,716 (4-30-11 10K iss. 7-14-11)
8-22-11 72,704,647 +1,634,789 (Proxy iss. 8-26-11)
8-31-11 73,284,016 +579,369 (424B5 iss. 9-2-11)
9-8-11 79,536,268 +6,252,252 (Roth Sale to 3 Inst’s @ $1.11/sh.)
10-31-11 82,638,201 +3,101,933
12-9-11 86,788,817 +4,150,616 (10-31-11 10Q iss. 12-12-11)
1-31-12 93,146,226 +6,357,409
2-29-12 98,873,172 +5,726,946 (1-31-12 10Q iss. 3-9-12)
4-30-12 101,421,365 +2,548,193
7-13-12 104,174,056 +2,752,691 (4-30-12 10K iss. 7-16-12)
8-16-12 104,191,176 +17,120** (prelim. proxy 14A http://tinyurl.com/c48bvof )

**8-15-12: CEO STEVE KING'S 29MIN. TALK AT WEDBUSH/NYC http://tinyurl.com/8mhrtld
…SK: "We've laid out our strategy for financing the company; we've not been raising money thru the capital markets in any way. We're not currently planning on going out for, nor have we been actively involved in any other fund-raising activities. Right now, our stated goal is to pursue a debt-arrangement - with an asset like Avid Bioservices, we can get very preferential rates on raising debt-type funding right now, which we feel is the least-dilutive for the company. In fact, our stated goal is to raise $20-30mm thru a debt facility between now and out next earnings call on Sept. 10, 2012. With that capital in the bank, we’ll then will have a 1yr+ runway. We believe that will get us thru the partnering discussions, and then with a partner on board, then certainly we expect that’ll bring in the capital needed to move the company forward for what should hopefully be several years time period. So, that’s our goal – we have a nice, clean cap structure, minimal # of warrants, stock options – there’s no convertible debt on the books, so we think we’re in good shape as we continue to move the company forward into those successful partnering discussions.”

O/S WARRANTS & STOCK-OPTIONS A/O 4-30-2012:
From the 4-30-12 10-K (pg. F-30 & F-28):
...219,967 warrants o/s with wgt.avg. exercise price of $1.48 (exp. 12-19-2013) – none iss. in FY10-11-12.
...7,402,248 stock options exercisable & expected to vest, with a wgt.avg. exercise price of $2.93.

= = = = = = = = = = = = =
Latest 10K 4-30-12 iss. 7-16-12: http://tinyurl.com/79o57b2 PR: http://tinyurl.com/c8nytow (#Cash 4-30-12 $18.0mm)
= > # CFO Paul Lytle, 7-16-12 CC: ”Since 5-1-12, the start of FY’13, we have received over $7 million in customer deposits to secure this future mfg. capacity. Based on the current mfg. schedule, we expect to realize the revenue from these mfg. commitments over FY '13 and FY '14.” ( http://tinyurl.com/cs7spbz )
Latest 10Q 1-31-12 iss. 3-9-12 http://tinyurl.com/7h352ks PR: http://tinyurl.com/7z9qh23 (Cash 1-31-12 $19.8mm)
ALL SEC filings for PPHM: http://tinyurl.com/6d4jw8
PPHM's Corp. Bylaws (a/o 12-21-07): http://www.secinfo.com/dV3p8.u4av.d.htm
Poison Pill adopted 3-16-06: http://tinyurl.com/yvypvh - 44-pg SEC filing: http://tinyurl.com/5m57ut

= = = = = = = = = = = = = = = = = = =
A-T-M (At-The-Market) Sales 3-2009 - 6-30-12 ($89,674,000gr./51,785,558sh=$1.73/sh): http://tinyurl.com/bnd6o7d
…New ATM Agreement (up to $75mm) with MLV announced 12-29-10/8K: http://tinyurl.com/2a6w76g
...3-9-12: PPHM files shelf to sell up to $150mm common stock, warrants, S3: http://tinyurl.com/7dl7pjm

11-8-10: Kenneth Dart (Eastern Capital) acquires 7.1% stake (3,961,568) in PPHM http://tinyurl.com/24qctos
...2-14-12: Kenneth Dart adds 3,460,192, now 7,421,760 (8.55% a/o 12-9-11) http://tinyurl.com/7bb26j4

12-31-10: BlackRock Inc. (Larry Fink, CEO) accums 5.6% stake in Peregrine http://tinyurl.com/4oercf8

7-23-12: Ayer Capital Mgt. accums 5.39% stake in PPHM (5,610,236) http://tinyurl.com/97w8gjm

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist